SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the market digests strong Q1 results, including significant revenue growth and improved margins, alongside robust Q2 delivery guidance. Community sentiment is deeply divided, with many investors citing persistent, coordinated short-selling and market manipulation as the reason for the stock's muted price reaction to positive earnings.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is facing intense volatility as traders debate the company's Q1 growth against rising operating costs and concerns over potential earnings leaks. While some investors remain optimistic about the firm's global expansion, AI initiatives, and the upcoming removal of day trading restrictions, the community is deeply divided over whether current price levels offer a bargain or signal further downside.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending following the announcement of a proposed $100 million federal funding deal, which includes an equity stake for the U.S. government. Community sentiment is deeply divided, with bulls viewing the government backing as a major validation of the sector's growth potential, while bears are aggressively highlighting the resulting share dilution and the company's limited commercial revenue.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is surging as investors react to a milestone agreement where the company secured a $100 million government funding commitment tied to a strategic equity stake. The community is actively discussing this news as a major validation of the firm's neutral-atom technology and its role in the broader U.S. quantum infrastructure race, with many retail participants focused on the company's valuation gap compared to its industry peers.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is capturing significant investor attention following a major government initiative that provides substantial funding and equity stakes to several key players in the quantum computing sector. While the community remains divided over the long-term fundamentals and the actual impact of these capital infusions versus cash burn, the news has ignited speculative volume and sparked intense debate regarding which quantum stocks are best positioned for policy-driven momentum.

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Akari Therapeutics Plc - ADR

Akari Therapeutics

Akari Therapeutics is experiencing significant momentum and investor interest driven by recent breakthrough preclinical data for its lead ADC program and potential strategic partnerships. The community remains intensely focused on the stock's low float and the ongoing battle between bullish long-term holders anticipating a major catalyst and active short sellers.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is experiencing a significant surge in investor attention following the Trump administration's $1 billion grant, which positions the company to launch a landmark quantum chip foundry known as Anderon. The community is actively debating the company's long-term potential as a quantum leader versus smaller pure-play rivals, while also scrutinizing the broader implications of government equity stakes in the sector.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

TIGR is facing significant downward pressure and intense bearish speculation following news of a multi-year regulatory crackdown on overseas trading platforms, which triggered a sharp sell-off in shares. While some investors are betting on a recovery supported by strong fundamentals and record-breaking financial performance, the community remains deeply divided, with many actively discussing the stock's high volatility, potential manipulation, and the ongoing struggle between bulls hoping for a rebound and shorts seeking further downside.

Futu Holdings Ltd. engages in the provision of digitalized financial services. It offers securities brokerage and wealth management products. The company was founded by Leaf Hua Li in December 2007 and is headquartered in Hong Kong.

Futu Holdings Ltd - ADR

Futu Holdings is trending as investors react to a significant regulatory crackdown in China targeting overseas trading platforms, which triggered a sharp sell-off in the stock. While some traders view the resulting volatility as a potential entry point for a long-term hold, others are actively loading up on puts amid fears of further downside and regulatory turbulence.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba stock is seeing sharp volatility as investors weigh a significant earnings miss against management's aggressive pivot toward AI commercialization and positive sentiment surrounding high-stakes diplomatic talks between the U.S. and China. While some traders are betting on a recovery fueled by potential tariff relief and expanded access to advanced AI chips, others remain skeptical, viewing the stock as a long-term value trap plagued by persistent regulatory and macroeconomic risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a landmark oncology data program for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting will take place May 29June 2 in Chicago, IL. Together with its collaborators...

Natera's EXPAND Trial Enrollment Crosses 2,000 Patient Milestone

NTRA's EXPAND trial for Fetal Focus single-gene NIPT tops 2,000 patients, doubling in a year as new data spotlight its robust design.

Natera Announces Expansion in Austin, Creating What Is Believed to Be the Largest Sequencing Facility in the World

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a significant expansion of its operations, marking a major milestone in the companys continued growth and mission to improve outcomes for patients with cancer and other serious diseases. At its...

EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study 

Exelixis teams up with Merck to advance zanzalintinib in a phase III colorectal cancer study, expanding its pipeline beyond Cabometyx.

EXPAND Trial of Nateras Fetal Focus Single-Gene NIPT Surpasses >2,000 Patients Enrolled

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced that the EXPAND clinical trial has enrolled over 2,000 patients, more than doubling enrollment in the last 12 months. EXPAND is a prospective, blinded, multi-site clinical trial...

NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer

Natera wins FDA approval for Signatera CDx in bladder cancer, marking the first blood-based MRD companion diagnostic milestone.

Signatera CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved Signatera CDx as a companion diagnostic (CDx) for use with adjuvant atezolizumab (Tecentriq) immunotherapy in MIBC. This is the first...

Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -5.26% and +13.26%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Natera (NTRA) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Natera Reports First Quarter 2026 Financial Results

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the first quarter ended March 31, 2026. Recent Financial Highlights...

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

NTRA
Natera Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest NTRA News

NTRANatera Inc